Latest filing published 16 Jul 2024 for EyePoint Pharmaceuticals, Inc., €10k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
David R. Guyer, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in IVERIC bio, Inc. and EyePoint, Inc. We count 19 filings; the first trade dates from 30 December 2015 and the latest from 12 July 2024.
The open-market record consists of 11 sales, with no purchase. The totals exclude 11 filings filed without an amount. The rest of the record consists of 8 option exercises.
The newest entry dates from 16 July 2024: an option exercise of €10k, in EyePoint, Inc. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
19 of 19 declarations